Tag: Immunotherapy
AstraZeneca Halts Phase III eVOLVE-Lung02 Trial of Volrustomig in Advanced Lung Cancer
AstraZeneca has announced it is stopping its Phase III eVOLVE-Lung02 study, which was testing volrustomig combined with chemotherapy as a first-line treatment for metastatic non-small cell...
Immuneel Therapeutics and Tata Memorial Centre Partner to Advance Cell & Gene Therapy in India
Immuneel Therapeutics Pvt. Ltd. has announced a strategic collaboration with the Tata Memorial Centre (TMC) to advance Cell & Gene Therapy (CGT) research and development in India.
This...
